Study Finds Coffee Tied to ‘Younger’ Biological Age in People with Mental Illness

Key Takeaways

• 3‑4 cups daily linked to longer telomeres in severe mental illness
• Telomere length suggested 5‑year younger biological age versus non‑drinkers
• No telomere benefit observed for 5+ cups per day
• Study controlled for age, sex, smoking, diagnosis and medication
• Results underscore coffee’s antioxidant and anti‑inflammatory potential

Pulse Analysis

The recent BMJ Mental Health paper adds a new dimension to the growing body of research linking coffee consumption with longevity. By focusing on a cohort of 436 adults with schizophrenia, bipolar disorder, or major depressive disorder with psychosis, the investigators were able to isolate telomere length—a proxy for cellular age—as an outcome. Their adjusted analyses suggest that a moderate intake of three to four cups per day correlates with telomeres that resemble those of individuals roughly five years younger, a finding that could partially explain why coffee drinkers often enjoy lower mortality rates in the general population.

Understanding why this effect appears only at moderate levels is crucial. Coffee is rich in polyphenols, chlorogenic acids, and other antioxidants that combat oxidative stress, a known driver of telomere attrition. Anti‑inflammatory compounds may also protect chromosomal ends from damage, especially in patients whose psychiatric conditions and associated treatments elevate systemic inflammation. However, the study’s observational design precludes definitive cause‑and‑effect claims; higher consumption (five-plus cups) showed no added benefit, possibly reflecting diminishing returns or confounding lifestyle factors such as sleep disruption or increased caffeine tolerance.

For clinicians and policymakers, the findings suggest a potential, low‑cost adjunct to existing strategies aimed at reducing the mortality gap for people with severe mental illness. Future randomized trials should test whether prescribed coffee intake can meaningfully extend healthspan, while also monitoring cardiovascular and metabolic outcomes. Until then, recommending moderate coffee consumption—aligned with existing dietary guidelines—may be a pragmatic step for patients seeking to improve both mental and physical well‑being.